{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T09:27:51Z","timestamp":1777800471039,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s10637-013-9985-0","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T07:55:56Z","timestamp":1371023756000},"page":"1330-1338","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sunitinib malate in previously untreated, nonsquamous, non-small cell lung cancer patients over the age of 70\u00a0years: Results of a Phase II trial"],"prefix":"10.1007","volume":"31","author":[{"given":"Craig","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander I.","family":"Spira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry","family":"Gluck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne E.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristi A.","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Asmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,1]]},"reference":[{"issue":"6","key":"9985_CR1","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1200\/JCO.2001.19.6.1734","volume":"19","author":"OS Breathnach","year":"2001","unstructured":"Breathnach OS, Freidlin B, Conley B, Green MR, Johnson DH, Gandara DR, O\u2019Connell M, Shepherd FA, Johnson BE (2001) Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results. J Clin Oncol 19(6):1734\u20131742","journal-title":"J Clin Oncol"},{"issue":"21","key":"9985_CR2","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1200\/JCO.2007.15.0375","volume":"26","author":"GV Scagliotti","year":"2008","unstructured":"Scagliotti GV, Parikh P, von Pawel J, Biesma B, Vansteenkiste J, Manegold C, Serwatowski P, Gatzemeier U, Digumarti R, Zukin M, Lee JS, Mellemgaard A, Park K, Patil S, Rolski J, Goksel T, de Marinis F, Simms L, Sugarman KP, Gandara D (2008) Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 26(21):3543\u20133551, Epub 2008 May 27","journal-title":"J Clin Oncol"},{"issue":"24","key":"9985_CR3","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1056\/NEJMoa061884","volume":"355","author":"A Sandler","year":"2006","unstructured":"Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A et al (2006) Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355(24):2542\u20132550, Erratum in: N Engl J Med 2007 Jan 18;356(3):318","journal-title":"N Engl J Med"},{"key":"9985_CR4","doi-asserted-by":"publisher","first-page":"133S","DOI":"10.1378\/chest.117.4_suppl_1.133S","volume":"117","author":"DH Johnson","year":"2000","unstructured":"Johnson DH (2000) Evolution of cisplatin-based chemotherapy in non-small cell lung cancer. Chest 117:133S\u2013137S","journal-title":"Chest"},{"issue":"1","key":"9985_CR5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1200\/JCO.2007.13.1144","volume":"26","author":"SS Ramalingam","year":"2008","unstructured":"Ramalingam SS, Dahlberg SE, Langer CJ, Gray R, Belani CP, Brahmer JR, Sandler AB, Schiller JH, Johnson DH, Group ECO (2008) Outcomes for elderly, advanced-stage non-small-cell lung cancer patients treated with bevacizumab in combination with carboplatin and paclitaxel: analysis of Eastern Cooperative Oncology Group Trial 4599. J Clin Oncol 26(1):60\u201365","journal-title":"J Clin Oncol"},{"issue":"15","key":"9985_CR6","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1001\/jama.2012.454","volume":"307","author":"J Zhu","year":"2012","unstructured":"Zhu J, Sharma DB, Gray SW, Chen AB, Weeks JC, Schrag D (2012) Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer. JAMA 307(15):1593\u20131601","journal-title":"JAMA"},{"issue":"3","key":"9985_CR7","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S1470-2045(12)70063-3","volume":"13","author":"L Paz-Ares","year":"2012","unstructured":"Paz-Ares L, de Marinis F, Dediu M, Thomas M, Pujol JL, Bidoli P, Molinier O, Sahoo TP, Laack E, Reck M, Corral J, Melemed S, John W, Chouaki N, Zimmermann AH, Visseren-Grul C, Gridelli C (2012) Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trial. Lancet Oncol 13(3):247\u2013255, Epub 2012 Feb 16","journal-title":"Lancet Oncol"},{"issue":"3","key":"9985_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cllc.2011.03.015","volume":"12","author":"A Karampeazis","year":"2011","unstructured":"Karampeazis A, Vamvakas L, Agelidou A, Kentepozidis N, Chainis K, Chandrinos V, Vardakis N, Pallis AG, Christophyllakis C, Georgoulias V (2011) Docetaxel vs. vinorelbine in elderly patients with advanced non-small-cell lung cancer: a hellenic oncology research group randomized phase III study. Clin Lung Cancer 12(3):155\u2013160, Epub 2011 Apr 27","journal-title":"Clin Lung Cancer"},{"issue":"4","key":"9985_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3816\/CLC.2005.n.004","volume":"6","author":"MA Neubauer","year":"2005","unstructured":"Neubauer MA, Reynolds CH, Joppert MG, Whitaker T, Ghaddar H, Marsland TA, Asmar L (2005) Results of a phase II trial of gemcitabine in patients with non-small-cell lung cancer and a performance status of 2. Clin Lung Cancer 6(4):245\u2013249","journal-title":"Clin Lung Cancer"},{"issue":"34","key":"9985_CR10","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.1200\/JCO.2009.21.9766","volume":"27","author":"C Reynolds","year":"2009","unstructured":"Reynolds C, Obasaju C, Schell MJ, Li X, Zheng Z, Boulware D, Caton JR, Demarco LC, O\u2019Rourke MA, Shaw Wright G, Boehm KA, Asmar L, Bromund J, Peng G, Monberg MJ, Bepler G (2009) Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer. J Clin Oncol 27(34):5808\u20135815, Epub 2009 Nov 2","journal-title":"J Clin Oncol"},{"issue":"9796","key":"9985_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/S0140-6736(11)60780-0","volume":"378","author":"E Quoix","year":"2011","unstructured":"Quoix E, Zalcman G, Oster JP, Westeel V (2011) Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 378(9796):1079\u20131088, Epub 2011 Aug 8","journal-title":"Lancet"},{"issue":"1","key":"9985_CR12","first-page":"327","volume":"9","author":"DB Mendel","year":"2003","unstructured":"Mendel DB, Laird AD, Xin X, Louie SG, Christensen JG, Li G et al (2003) In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship. Clin Cancer Res Jan 9(1):327\u2013337","journal-title":"Clin Cancer Res Jan"},{"issue":"4","key":"9985_CR13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1200\/JCO.2007.13.9303","volume":"26","author":"MA Socinski","year":"2008","unstructured":"Socinski MA, Novello S, Brahmer JR et al (2008) Multicenter, phase II trial of sunitinib in previously treated, advanced non-small cell lung cancer. J Clin Oncol 26(4):650\u2013656","journal-title":"J Clin Oncol"},{"key":"9985_CR14","unstructured":"FACT-L: For patients with Lung cancer. Available at URL: https:\/\/doi.org\/www.facit.org\/FACITOrg\/Questionnaires (accessed February 12, 2012) (FACIT.org)"},{"key":"9985_CR15","unstructured":"FACT-G: Functional Assessment of Cancer Therapy\u2014General. Available at URL: https:\/\/doi.org\/www.facit.org\/FACITOrg\/Questionnaires (accessed February 12, 2012)"},{"key":"9985_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"9985_CR17","unstructured":"Cancer Therapy Evaluation Program. Common terminology criteria for adverse events v3.0 (CTCAE). Available at https:\/\/doi.org\/www.ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm. Accessed June 6, 2011"},{"key":"9985_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","volume":"10","author":"R Simon","year":"1989","unstructured":"Simon R (1989) Optimal two-stage designs for phase II clinical trials. Control Clin Trials 10:1\u201310","journal-title":"Control Clin Trials"},{"key":"9985_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. JASA 53:457\u2013481","journal-title":"JASA"},{"issue":"5","key":"9985_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.rmr.2010.03.011","volume":"27","author":"C Raynaud","year":"2010","unstructured":"Raynaud C, Le Caer H, Borget I, Jullian H, Locher C, Chouaid C, Groupe fran\u00e7ais de pneumocanc\u00e9rologie (2010) Comprehensive geriatric assessment and complications after resection for lung cancer. Rev Mal Respir 27(5):483\u2013488, French","journal-title":"Rev Mal Respir"},{"issue":"1","key":"9985_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.lungcan.2010.07.001","volume":"72","author":"R Giron\u00e9s","year":"2011","unstructured":"Giron\u00e9s R, Torregrosa D, G\u00f3mez-Codina J, Maestu I, Tenias JM, Rosell R (2011) Prognostic impact of comorbidity in elderly lung cancer patients: use and comparison of two scores. Lung Cancer 72(1):108\u2013113, Epub 2010 Aug 19","journal-title":"Lung Cancer"},{"issue":"7","key":"9985_CR22","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1093\/annonc\/mdq637","volume":"22","author":"B Biesma","year":"2011","unstructured":"Biesma B, Wymenga AN, Vincent A, Dalesio O, Smit HJ, Stigt JA, Smit EF, van Felius CL, van Putten JW, Slaets JP, Groen HJ, Dutch Chest Physician Study Group (2011) Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. Ann Oncol 22(7):1520\u20131527, Epub 2011 Jan 20","journal-title":"Ann Oncol"}],"updated-by":[{"DOI":"10.1007\/s10637-013-9996-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,7,6]],"date-time":"2013-07-06T00:00:00Z","timestamp":1373068800000}}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-013-9985-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10637-013-9985-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-013-9985-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10637-013-9985-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T04:39:39Z","timestamp":1678509579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10637-013-9985-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["9985"],"URL":"https:\/\/doi.org\/10.1007\/s10637-013-9985-0","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s10637-013-9996-x","asserted-by":"object"}]},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"2 May 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}